Xi Jinping, general secretary of the Communist Party of China (CPC) Central Committee, who is also Chinese president and chairman of the Central Military Commission, speaks at the national conference on organizational work in Beijing, capital of China. The conference was held here from July 3 to 4, 2018. [Photo/Xinhua] BEIJING -- Xi Jinping, general secretary of the Communist Party of China Central Committee, has called on Party members to share the Party's burdens and encourage those who get rich first to help latecomers in the battle against poverty. Responding to a letter from rural Party members in Zhejiang province proposing to donate tea seedlings to poor areas, Xi, also Chinese president and chairman of the Central Military Commission, said that Party members should never forget where one's source of benefit comes from and be grateful for what the Party has done for them, and this is of great significance in winning the battle against poverty. In April, 20 rural Party members from Huangdu village in Zhejiang wrote a letter to Xi, reporting how the village gets rich by growing tea and proposing to donate 15 million tea seedlings to help impoverished regions lift more people out of poverty. Following Xi's instruction, the State Council Leading Group Office of Poverty Alleviation and Development specified 34 villages in the provinces of Hunan, Sichuan and Guizhou to receive the donation. The plan is expected to help 5,839 poor people in 1,862 households in the regions increase income and get rid of poverty. bat fidget spinner24 hour wristbands.comcustom made rubber braceletsfabric wristbandscustom sweatbands no minimumadjustable wristbands24 wristbandscustom wrist sweatbands
NANJING - China Food and Drug Administration (FDA) has approved the sale of a new drug for the treatment of HIV-1 infection, the maker of the drug said.Aikening, or albuvirtide for injection (ABT), can be used with other antiretroviral drugs to treat infected patients who have been treated with antiviral drugs but still suffer from viral replication, according to Frontier Biotech, a pharmaceutical company based in the east Chinese city of Nanjing.Data from clinical trials showed that Aikening was effective against major strains of HIV, including resistant viruses, and the efficacy was long-acting, according to the company.As a long-acting injectable drug with a new mechanism of action, ABT has the potential to be a significant addition and improvement to the currently all oral drug regimen, said Xie Dong, chairman of Frontier Biotech.Patients who used Aikening didn't show severe symptoms of side-effects, and they only have to take one injection every week, according to the company.It is expected that Aikening will have a big potential in markets at home and abroad, said Li Taisheng, an AIDS expert with Peking Union Medical College Hospital.Official data showed that as of June last year, China had about 718,270 people living with HIV/AIDS and 221,628 people had died of AIDS-related diseases.
